Medical Developments International

About

Medical Developments International (MDI) is an Australian-based global leader in the manufacture and supply of acute pain management and respiratory products. Their offerings include analgesia delivery systems for trauma and procedural pain, as well as respiratory devices designed to assist patients with asthma and chronic obstructive pulmonary disease (COPD). Operating across more than 40 countries and listed on the Australian Stock Exchange (ASX), MDI is committed to maintaining high standards of safety and efficacy. With a growing emphasis on cyber resilience, MDI sought a security partner to help fortify their defences in the face of evolving cybersecurity threats.

Challenges

Historically, MDI’s focus had been on product innovation and global expansion, with cybersecurity receiving limited attention. As a publicly listed company, MDI faced heightened regulatory scrutiny and an increasing volume of cyber risks to their sensitive data and operational integrity. Recognising these risks, the company sought an in-depth review of their cybersecurity practices. They required a robust audit to pinpoint vulnerabilities, ensure compliance, and mitigate reputational and operational risks.

MDI identified the Essential 8 framework as a strategic method to guide their improvement, but they lacked the internal expertise to evaluate their current maturity level and develop an actionable plan. As a result, they sought external support to help bridge the gap, increase their cyber resilience, and enhance their preparedness for future threats.

Solution

Oreta stepped in to perform a comprehensive Essential 8 audit, providing MDI with an objective assessment of their cybersecurity maturity. The audit involved a deep dive into MDI’s existing security controls, uncovering critical weaknesses across key areas such as patch management, user authentication, and data backup practices. Oreta’s experts presented a detailed roadmap tailored to MDI’s specific needs and business requirements.

The roadmap was divided into three phases, each designed to gradually increase MDI’s cybersecurity maturity, moving them closer to full alignment with Essential 8 recommendations. This phased approach ensured that the improvements were both sustainable and aligned with the organisation’s broader business strategy. Oreta’s support extended beyond just identifying gaps; they also helped MDI prioritise and implement key security measures, such as multi-factor authentication and automated patching, to address the most pressing risks.

Outcome

  • MDI achieved a clearer understanding of their current security posture, with critical vulnerabilities identified and addressed.
  • Development of a three-phase roadmap designed to elevate MDI’s Essential 8 maturity to level 3, systematically enhancing their resilience over time.
  • Strengthened stakeholder confidence in MDI’s cybersecurity strategy, particularly important for an ASX-listed organisation.
  • Improved regulatory compliance and reduced risk of data breaches, ensuring better protection for their sensitive medical data and intellectual property.